You are here: Home: BCU 9|2003 - Supplement : Case 2: From the practice of Thomas G Frazier, MD: Select publications

Select publications

Adjuvant therapy in the elderly

The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer. Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer 2003;98:1802-10. Abstract

Balducci L et al. Management of breast cancer in the older woman. Cancer Control. 2001;8(5):431-41. Abstract

Bouchardy C et al. Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 2003;21(19):3580-7. Abstract

Crivellari D et al. Treatment of older breast cancer patients with high recurrence risk. Crit Rev Oncol Hematol 2003;46(3):241-6. Abstract

Du XL et al. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002;20(24):4636-42. Abstract

Fisher B et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002;20(20):4141-9. Abstract

Grogan M et al. Estimating the benefits of adjuvant systemic therapy for women with early breast cancer. Br J Surg 2001;88(11):1513-8. Abstract

Mandelblatt JS et al. Predictors of long-term outcomes in older breast cancer survivors: Perceptions versus patterns of care. J Clin Oncol 2003;21(5):855-63. Abstract

Muss HB. Adjuvant therapy for older women with breast cancer. Breast 2003;12(6):550-7. Abstract

Punglia RS et al. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: A decision analysis. J Clin Oncol 2003;21(12):2260-7. Abstract

Woodard S et al. Older women with breast carcinoma are less likely to receive adjuvant chemotherapy: Evidence of possible age bias? Cancer 2003;98(6):1141-9. Abstract

Sentinel node biopsy

Blanchard DK et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003;138(5):482-7;discussion 487-8. Abstract

Cox CE et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 2002;8(2):88-91. Abstract

DiFronzo LA et al. Does sentinel lymphadenectomy improve staging and alter therapy in elderly women with breast cancer? Ann Surg Oncol 2000;7(6):406-10. Abstract

Fant JS et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003;10(2):126-30. Abstract

Guenther JM et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003;138(1):52-6. Abstract

Jakub JW et al. Current status of sentinel lymph node mapping and biopsy: Facts and controversies. Oncologist 2003;8(1):59-68. Abstract

Mamounas EP. Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 2003;83(4):931-42. Abstract

Reitsamer R et al. Sentinel lymph node biopsy alone without axillary lymph node dissection -follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 2003;29(3):221-3. Abstract

Sanidas EE et al. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer? Am J Surg 2003;185(3):202-10. Abstract

Schwartz GF et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol 2002;33(6):579-89. Abstract

Veronesi U et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349(6):546-53. Abstract

Wilke LG, Giuliano A. Sentinel lymph node biopsy in patients with early-stage breast cancer: Status of the National Clinical Trials. Surg Clin North Am 2003;83(4):901-10. Abstract

 

Table of Contents Top of Page

 

 

Home · Search

Editor’s Note:
The Real World
 
2003 Breast Cancer Update Working Group Participants
 
 
Case 1: 37-year-old woman with multiple positive axillary nodes
and an ER-positive, HER2-positive breast cancer
   - Select publications
 
Case 2: 72-year-old woman with an ER-positive, sentinel node positive breast cancer who wishes to avoid postlumpectomy breast irradiation
  - Select publications
 
Case 3: 73-year-old nurse with a 6.5-cm primary breast cancer
  - Select publications
 
Case 4: 52-year-old woman with a malignant pericardial effusion
  - Select publications
 
Case 5: 72-year-old woman with bilateral pulmonary nodules 39 years after breast cancer treatment
  - Select publications
 
Case 6: 58-year-old woman with a history of treatment for carcinomatous meningitis
  - Select publications
 
Case 7: 76-year-old woman with multiple skin and subcutaneous nodules seven years after completing five years of adjuvant tamoxifen
  - Select publications
 
Home · Contact us
Terms of use and general disclaimer